eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
5.25
-0.02 (-0.38%)
Oct 9, 2026, 4:00 PM EDT - Market closed
eXoZymes Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | - | - | - | 0.07 | - | - |
Other Revenue | - | - | - | - | 0.03 | - |
| - | - | - | 0.07 | 0.03 | - | |
Revenue Growth | - | - | - | 145.01% | - | - |
Gross Profit | - | - | - | 0.07 | 0.03 | - |
Selling, General & Admin | 5.67 | 6.01 | 4.06 | 1.34 | 0.98 | 0.84 |
Research & Development | 4.89 | 3.71 | 1.87 | 0.53 | 0.38 | 0.45 |
Operating Expenses | 10.56 | 9.72 | 5.93 | 1.87 | 1.36 | 1.29 |
Operating Income | -10.56 | -9.72 | -5.93 | -1.8 | -1.33 | -1.29 |
Interest & Investment Income | 0.21 | 0.36 | 0.08 | 0 | 0 | - |
Other Non Operating Income (Expenses) | 0.05 | 0.09 | -0.01 | -0.2 | - | - |
EBT Excluding Unusual Items | -10.3 | -9.26 | -5.86 | -2 | -1.33 | -1.29 |
Other Unusual Items | - | - | - | - | - | 0.08 |
Pretax Income | -10.3 | -9.26 | -5.86 | -2 | -1.33 | -1.21 |
Income Tax Expense | -0.11 | -0.11 | - | 0.04 | 0.06 | - |
Net Income | -10.19 | -9.16 | -5.86 | -2.04 | -1.4 | -1.21 |
Net Income to Common | -10.19 | -9.16 | -5.86 | -2.04 | -1.4 | -1.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 7 | 6 | 6 | 5 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 6 | 6 | 5 |
Shares Change | 11.18% | 27.70% | 5.01% | 4.72% | 15.14% | - |
EPS (Basic) | -1.20 | -1.09 | -0.89 | -0.33 | -0.23 | -0.23 |
EPS (Diluted) | -1.20 | -1.09 | -0.89 | -0.33 | -0.23 | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.14 | -6.67 | -8.9 | -1.47 | -1.44 | -2.01 |
Free Cash Flow Per Share | -0.84 | -0.80 | -1.36 | -0.23 | -0.24 | -0.39 |
Gross Margin | - | - | - | 100.00% | 100.00% | - |
Operating Margin | - | - | - | -2563.51% | -4660.00% | - |
Profit Margin | - | - | - | -2909.12% | -4881.91% | - |
Free Cash Flow Margin | - | - | - | -2097.34% | -5046.08% | - |
EBITDA | -10.26 | -9.43 | -5.66 | -1.6 | -1.18 | -1.23 |
D&A For EBITDA | 0.3 | 0.29 | 0.27 | 0.2 | 0.15 | 0.06 |
EBIT | -10.56 | -9.72 | -5.93 | -1.8 | -1.33 | -1.29 |
Revenue as Reported | - | - | - | - | 0.03 | - |